Recent studies showed that these two PSP subtypes displayed different levels of peripheral biomarkers such as glial-derived neurotrophic factor and hepcidin [47,48]; thus, it is possible to hypothesize that different PSP subtypes might have different levels of p-tau396. The gene discussed is HAMP; the disease is supranuclear palsy, progressive, 1.